Pathogenic VCP/TER94 Alleles Are Dominant Actives and Contribute to Neurodegeneration by Altering Cellular ATP Level in a IBMPFD Model

English version České info

Inclusion body myopathy with Paget's disease of bone and frontotemporal dementia (IBMPFD) is caused by mutations in Valosin-containing protein (VCP), a hexameric AAA ATPase that participates in a variety of cellular processes such as protein degradation, organelle biogenesis, and cell-cycle regulation. To understand how VCP mutations cause IBMPFD, we have established a Drosophila model by overexpressing TER94 (the sole Drosophila VCP ortholog) carrying mutations analogous to those implicated in IBMPFD. Expression of these TER94 mutants in muscle and nervous systems causes tissue degeneration, recapitulating the pathogenic phenotypes in IBMPFD patients. TER94-induced neurodegenerative defects are enhanced by elevated expression of wild-type TER94, suggesting that the pathogenic alleles are dominant active mutations. This conclusion is further supported by the observation that TER94-induced neurodegenerative defects require the formation of hexamer complex, a prerequisite for a functional AAA ATPase. Surprisingly, while disruptions of the ubiquitin-proteasome system (UPS) and the ER–associated degradation (ERAD) have been implicated as causes for VCP–induced tissue degeneration, these processes are not significantly affected in our fly model. Instead, the neurodegenerative defect of TER94 mutants seems sensitive to the level of cellular ATP. We show that increasing cellular ATP by independent mechanisms could suppress the phenotypes of TER94 mutants. Conversely, decreasing cellular ATP would enhance the TER94 mutant phenotypes. Taken together, our analyses have defined the nature of IBMPFD–causing VCP mutations and made an unexpected link between cellular ATP level and IBMPFD pathogenesis.

Vyšlo v časopise: Pathogenic VCP/TER94 Alleles Are Dominant Actives and Contribute to Neurodegeneration by Altering Cellular ATP Level in a IBMPFD Model. PLoS Genet 7(2): e32767. doi:10.1371/journal.pgen.1001288
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001288

Souhrn

Zdroje

1. WattsGD

WymerJ

KovachMJ

MehtaSG

MummS

2004

Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein.

Nat Genet

377

381

2. DaiRM

LiCC

2001

Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation.

Nat Cell Biol

740

744

3. JaroschE

TaxisC

VolkweinC

BordalloJ

FinleyD

2002

Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48.

Nat Cell Biol

134

139

4. LatterichM

FröhlichKU

SchekmanR

1995

Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes.

Cell

885

893

5. RabouilleC

LevineTP

PetersJM

WarrenG

1995

An NSF-like ATPase, p97, and NSF mediate cisternal regrowth from mitotic Golgi fragments.

Cell

905

914

6. KondoH

RabouilleC

NewmanR

LevineTP

PappinD

1997

p47 is a cofactor for p97-mediated membrane fusion.

Nature

388

7. HetzerM

MeyerHH

WaltherTC

Bilbao-CortesD

WarrenG

2001

Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly.

Nat Cell Biol

1086

1091

8. CaoK

NakajimaR

MeyerHH

ZhengY

2003

The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis.

Cell

115

355

367

9. ZhangX

ShawA

BatesPA

NewmanRH

GowenB

2000

Structure of the AAA ATPase p97.

Mol Cell

1473

1484

10. DeLaBarreB

BrungerAT

2003

Complete structure of p97/valosin-containing protein reveals communication between nucleotide domains.

Nat Struct Biol

856

863

11. RouillerI

ButelVM

LatterichM

MilliganRA

Wilson-KubalekEM

2000

A major conformational change in p97 AAA ATPase upon ATP binding.

Mol Cell

1485

1490

12. DaviesJM

BrungerAT

WeisWI

2008

Improved structures of full-length p97, an AAA ATPase: implications for mechanisms of nucleotide-dependent conformational change.

Structure

715

726

13. SongC

WangQ

LiCC

2003

ATPase activity of p97-valosin-containing protein (VCP). D2 mediates the major enzyme activity, and D1 contributes to the heat-induced activity.

J Biol Chem

278

3648

3655

14. OguraT

WilkinsonAJ

2001

AAA+ superfamily ATPases: common structure–diverse function.

Genes Cells

575

597

15. HalawaniD

LeBlancAC

RouillerI

MichnickSW

ServantMJ

2009

Hereditary inclusion body myopathy-linked p97/VCP mutations in the NH2 domain and the D1 ring modulate p97/VCP ATPase activity and D2 ring conformation.

Mol Cell Biol

4484

4494

16. KobayashiT

TanakaK

InoueK

KakizukaA

2002

Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells.

J Biol Chem

277

47358

47365

17. MeyerHH

KondoH

WarrenG

1998

The p47 co-factor regulates the ATPase activity of the membrane fusion protein, p97.

FEBS Lett

437

255

257

18. UchiyamaK

TotsukawaG

PuhkaM

KanekoY

JokitaloE

2006

p37 is a p97 adaptor required for Golgi and ER biogenesis in interphase and at the end of mitosis.

Dev Cell

803

816

19. YeY

MeyerHH

RapoportTA

2001

The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol.

Nature

414

652

656

20. KimonisVE

FulchieroE

VesaJ

WattsG

2008

VCP disease associated with myopathy, Paget disease of bone and frontotemporal dementia: review of a unique disorder.

Biochim Biophys Acta

1782

744

748

21. WeihlCC

MillerSE

HansonPI

PestronkA

2007

Transgenic expression of inclusion body myopathy associated mutant p97/VCP causes weakness and ubiquitinated protein inclusions in mice.

Hum Mol Genet

919

928

22. WeihlCC

DalalS

PestronkA

HansonPI

2006

Inclusion body myopathy-associated mutations in p97/VCP impair endoplasmic reticulum-associated degradation.

Hum Mol Genet

189

199

23. JuJS

FuentealbaRA

MillerSE

JacksonE

Piwnica-WormsD

2009

Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease.

J Cell Biol

187

875

888

24. VesaJ

SuH

WattsGD

KrauseS

WalterMC

2009

Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts.

Neuromuscul Disord

766

772

25. RitsonGP

CusterSK

FreibaumBD

GuintoJB

GeffelD

2010

TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97.

J Neurosci

7729

7739

26. PintérM

JékelyG

SzepesiRJ

FarkasA

TheopoldU

1998

TER94, a Drosophila homolog of the membrane fusion protein CDC48/p97, is accumulated in nonproliferating cells: in the reproductive organs and in the brain of the imago.

Insect Biochem Mol Biol

27. BrandAH

PerrimonN

1993

Targeted gene expression as a means of altering cell fates and generating dominant phenotypes.

Development

118

401

415

28. GrothAC

FishM

NusseR

CalosMP

2004

Construction of transgenic Drosophila by using the site-specific integrase from phage phiC31.

Genetics

166

1775

1782

29. DiAntonioA

PetersenSA

HeckmannM

GoodmanCS

1999

Glutamate receptor expression regulates quantal size and quantal content at the Drosophila neuromuscular junction.

J Neurosci

3023

3032

30. WeihlCC

PestronkA

KimonisVE

2009

Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Neuromuscul Disord

308

315

31. van der ZeeJ

GijselinckI

PiriciD

Kumar-SinghS

CrutsM

2007

Frontotemporal lobar degeneration with ubiquitin-positive inclusions: a molecular genetic update.

Neurodegener Dis

227

235

32. Moreau-FauvarqueC

TaillebourgE

BoissoneauE

MesnardJ

DuraJM

1998

The receptor tyrosine kinase gene linotte is required for neuronal pathway selection in the Drosophila mushroom bodies.

Mech Dev

33. BilenJ

BoniniNM

2005

Drosophila as a model for human neurodegenerative disease.

Annu Rev Genet

153

171

34. JuJS

MillerSE

HansonPI

WeihlCC

2008

Impaired protein aggregate handling and clearance underlie the pathogenesis of p97/VCP-associated disease.

J Biol Chem

283

30289

30299

35. PandeyUB

NieZ

BatleviY

McCrayBA

RitsonGP

2007

HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS.

Nature

447

859

863

36. YangH

ParkhouseRM

1998

Differential activation requirements associated with stimulation of T cells via different epitopes of CD3.

Immunology

37. Menéndez-BenitoV

VerhoefLG

MasucciMG

DantumaNP

2005

Endoplasmic reticulum stress compromises the ubiquitin-proteasome system.

Hum Mol Genet

2787

2799

38. RyooHD

DomingosPM

KangMJ

StellerH

2007

Unfolded protein response in a Drosophila model for retinal degeneration.

Embo J

242

252

39. WangQ

SongC

IrizarryL

DaiR

ZhangX

2005

Multifunctional roles of the conserved Arg residues in the second region of homology of p97/valosin-containing protein.

J Biol Chem

280

40515

40523

40. MannoA

NoguchiM

FukushiJ

MotohashiY

KakizukaA

2010

Enhanced ATPase activities as a primary defect of mutant valosin-containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia.

Genes Cells

911

922

41. LieberthalW

MenzaSA

LevineJS

1998

Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells.

Am J Physiol

274

F315

327

42. GuarenteL

2008

Mitochondria–a nexus for aging, calorie restriction, and sirtuins?

Cell

132

171

176

43. RedmanLM

HeilbronnLK

MartinCK

de JongeL

WilliamsonDA

2009

Metabolic and behavioral compensations in response to caloric restriction: implications for the maintenance of weight loss.

PLoS ONE

e4377

doi:10.1371/journal.pone.0004377

44. NivenJE

VähäsöyrinkiM

KauranenM

HardieRC

JuusolaM

2003

The contribution of Shaker K+ channels to the information capacity of Drosophila photoreceptors.

Nature

421

630

634

45. MarshJL

WalkerH

TheisenH

ZhuYZ

FielderT

2000

Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.

Hum Mol Genet

46. SangTK

LiC

LiuW

RodriguezA

AbramsJM

2005

Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis.

Hum Mol Genet

357

372

47. WarrickJM

PaulsonHL

Gray-BoardGL

BuiQT

FischbeckKH

1998

Expanded polyglutamine protein forms nuclear inclusions and causes neural degeneration in Drosophila.

Cell

939

949

48. JacobsonSG

McInnesRR

2002

Blinded by the light.

Nat Genet

215

216

49. KnowlesSE

JarrettIG

FilsellOH

BallardFJ

1974

Production and utilization of acetate in mammals.

Biochem J

142

401

411

50. SouthonA

BurkeR

NorgateM

BatterhamP

CamakarisJ

2004

Copper homoeostasis in Drosophila melanogaster S2 cells.

Biochem J

383

303

309

51. PagliariniDJ

WileySE

KimpleME

DixonJR

KellyP

2005

Involvement of a mitochondrial phosphatase in the regulation of ATP production and insulin secretion in pancreatic beta cells.

Mol Cell

197

207

52. DietzlG

ChenD

SchnorrerF

SuKC

BarinovaY

2007

A genome-wide transgenic RNAi library for conditional gene inactivation in Drosophila.

Nature

448

151

156

53. StojkovicT

Hammouda elH

RichardP

López de MunainA

Ruiz-MartinezJ

2009

Clinical outcome in 19 French and Spanish patients with valosin-containing protein myopathy associated with Paget's disease of bone and frontotemporal dementia.

Neuromuscul Disord

316

323

54. HalawaniD

LatterichM

2006

p97: The cell's molecular purgatory?

Mol Cell

713

717

55. HübbersCU

ClemenCS